Skip to content
  • KOSPI 2559.79 +3.18 +0.12%
  • KOSDAQ 721.86 +4.62 +0.64%
  • KOSPI200 338.79 +0.05 +0.01%
  • USD/KRW 1426 12.00 -0.84%
View Market Snapshot

Deals

Mergers & Acquisitions

MBK Partners poised to acquire CJ Cheiljedang’s $3.5 billion bio business

North Asia-focused private equity firm MBK Partners is on the verge of clinching a major acquisition deal by offering a higher bid than other contenders for South Korea’s CJ Cheiljedang Corp.'s bio business — a deal estimated at 5 trilli

Mar 06, 2025 (Gmt+09:00)

3 Min read